caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1588800080

Hussain GilaniM.D.

NephrologyOakland, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Hussain Gilani's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 73 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Yakuan Yvonne Chen
Nephrology · Oakland, CA
129668
Kathryn Klima
Diagnostic Radiology · Oakland, CA
96383
RICH, PHILIP69302
Linda Gordon
Diagnostic Radiology · San Jose, CA
63157
RAI CARE CENTERS OF NORTHERN CALIFORNIA II, LLC54726
SPECTRA LABORATORIES INC53679
Gwendolen Chang
Nephrology · San Leandro, CA
48122
Sangeeta Gambhir
Diagnostic Radiology · Walnut Creek, CA
44152
Eric Johnson
Interventional Cardiology · Oakland, CA
37124
Mitul Kadakia
Interventional Cardiology · Oakland, CA
36116
SUTTER EAST BAY HOSPITALS35115
Christopher Lee
Diagnostic Radiology · Walnut Creek, CA
3373
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,173
Unique beneficiaries
—
Total services
2,884
Distinct HCPCS
17
Medicare payment
$321K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 985 Nephrology providers in CA — top quintile (cohort median 1,482).
PRESCRIBING · PART D · 2024
Total Rx claims
2,559
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
37
Brand share
48.7%
Top prescribed drugs
Empagliflozin469 claims
Olmesartan Medoxomil363 claims
Dapagliflozin Propanediol200 claims
Finerenone156 claims
Amlodipine Besylate142 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$35K
Payment records
88
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$28K
Travel and Lodging$4K
Food and Beverage$3K
Education$39